Abstract
In this study, a beta-adrenergic blocker in combination with digoxin provided marginal protection against atrial fibrillation/flutter after coronary artery surgery. The economic comparison of patients who did and did not develop atrial fibrillation/flutter indicates that prevention of these arrhythmias can have a significant impact on length of hospital stay and cost of this common surgical procedure.
Publication types
-
Clinical Trial
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acebutolol / therapeutic use*
-
Aged
-
Anti-Arrhythmia Agents / therapeutic use*
-
Atrial Fibrillation / etiology
-
Atrial Fibrillation / prevention & control*
-
Atrial Flutter / etiology
-
Atrial Flutter / prevention & control*
-
Coronary Artery Bypass / adverse effects*
-
Digoxin / therapeutic use*
-
Drug Therapy, Combination
-
Female
-
Humans
-
Male
-
Middle Aged
-
Single-Blind Method
-
Time Factors
-
Treatment Outcome
Substances
-
Anti-Arrhythmia Agents
-
Acebutolol
-
Digoxin